Antibiotics Market Size to Worth Around USD 63 Billion by 2030
The report analyzes and forecasts the Antibiotics Market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2022 to 2030. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global Antibiotics Market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the Antibiotics Market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of Antibiotics Market for the base year 2020 and the forecast between 2021 and 2028. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Download Sample Report Copy From Here:https://www.acumenresearchandconsulting.com/request-sample/2504
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report. Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding. Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
Market Players as below:
The global antibiotics companies profiled in the report include Abbott Laboratories, Allergan plc, Basilea Pharmaceutica Ltd., Bayer Healthcare AG, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Johnson & Johnson Inc., Melinta Therapeutics, Merck & Co., Inc., Novartis AG, Pfizer Inc., Sanofi SA, and Tetraphase Pharmaceuticals.
The major market segments of Antibiotics Market are as below:
Antibiotics Market By Product Type
- Cephalosporins
- Penicillin
- Fluoroquinolones
- Macrolides
- Carbapenems
- Aminoglycosides
- Sulfonamides
- Other Product Types
Antibiotics Market By Drug Origin
- Natural
- Semi-Synthetic
- Synthetic
Antibiotics Market By Spectrum
- Broad-Spectrum Antibiotic
- Narrow-Spectrum Antibiotic
Antibiotics Market By Route of Administration
- Oral
- Intravenous
- Others
Antibiotics Market By Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
- Others
Ask Query Here: richard@acumenresearchandconsulting.com or sales@acumenresearchandconsulting.com
Table Of Contents:
CHAPTER 1. Industry Overview of Antibiotics Market
1.1. Definition and Scope
1.1.1. Definition of Antibiotics
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Antibiotics Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Antibiotics Market By Product Type
1.2.3. Antibiotics Market By Drug Origin
1.2.4. Antibiotics Market By Route of Administration
1.2.5. Antibiotics Market By Spectrum
1.2.6. Antibiotics Market By Distribution Channel
1.2.7. Antibiotics Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Antibiotics Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Antibiotics Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2021
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2021
4.2. R&D Status of Major Manufacturers in 2021
CHAPTER 5. Antibiotics Market By Product Type
5.1. Introduction
5.2. Antibiotics Revenue By Product Type
5.2.1. Antibiotics Revenue (USD Billion) and Forecast, By Product Type, 2018-2030
5.2.2. Penicillin
5.2.2.1. Penicillin Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.3. Cephalosporins
5.2.3.1. Cephalosporins Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.4. Fluoroquinolones
5.2.4.1. Fluoroquinolones Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.5. Macrolides
5.2.5.1. Macrolides Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.6. Carbapenems
5.2.6.1. Carbapenems Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.7. Aminoglycosides
5.2.7.1. Aminoglycosides Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.8. Sulfonamides
5.2.8.1. Sulfonamides Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.9. Other Product Types
5.2.9.1. Other Product Types Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 6. Antibiotics Market By Drug Origin
6.1. Introduction
6.2. Antibiotics Revenue By Drug Origin
6.2.1. Antibiotics Revenue (USD Billion) and Forecast, By Drug Origin, 2018-2030
6.2.2. Natural
6.2.2.1. Natural Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.3. Semi-Synthetic
6.2.3.1. Semi-Synthetic Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.4. Synthetic
6.2.4.1. Synthetic Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 7. Antibiotics Market By Route of Administration
7.1. Introduction
7.2. Antibiotics Revenue By Route of Administration
7.2.1. Antibiotics Revenue (USD Billion) and Forecast, By Route of Administration, 2018-2030
7.2.2. Oral
7.2.2.1. Oral Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
7.2.3. Intravenous
7.2.3.1. Intravenous Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
7.2.4. Others
7.2.4.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 8. Antibiotics Market By Spectrum
8.1. Introduction
8.2. Antibiotics Revenue By Spectrum
8.2.1. Antibiotics Revenue (USD Billion) and Forecast, By Spectrum, 2018-2030
8.2.2. Narrow-Spectrum Antibiotic
8.2.2.1. Narrow-Spectrum Antibiotic Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
8.2.3. Broad-spectrum Antibiotic
8.2.3.1. Broad-spectrum Antibiotic Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 9. Antibiotics Market By Distribution Channel
9.1. Introduction
9.2. Antibiotics Revenue By Distribution Channel
9.2.1. Antibiotics Revenue (USD Billion) and Forecast, By Distribution Channel, 2018-2030
9.2.2. Hospital Pharmacy
9.2.2.1. Hospital Pharmacy Antibiotic Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
9.2.3. Online Pharmacy
9.2.3.1. Online Pharmacy Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
9.2.4. Retail Pharmacy
9.2.4.1. Retail Pharmacy Antibiotic Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
9.2.5. Others
9.2.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 10. North America Antibiotics Market By Country
10.1. North America Antibiotics Market Overview
10.2. U.S.
10.2.1. U.S. Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030
10.2.2. U.S. Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030
10.2.3. U.S. Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
10.2.4. U.S. Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030
10.2.5. U.S. Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
10.3. Canada
10.3.1. Canada Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030
10.3.2. Canada Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030
10.3.3. Canada Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
10.3.4. Canada Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030
10.3.5. Canada Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
10.4. North America PEST Analysis
CHAPTER 11. Europe Antibiotics Market By Country
11.1. Europe Antibiotics Market Overview
11.2. U.K.
11.2.1. U.K. Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030
11.2.2. U.K. Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030
11.2.3. U.K. Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
11.2.4. U.K. Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030
11.2.5. U.K. Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
11.3. Germany
11.3.1. Germany Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030
11.3.2. Germany Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030
11.3.3. Germany Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
11.3.4. Germany Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030
11.3.5. Germany Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
11.4. France
11.4.1. France Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030
11.4.2. France Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030
11.4.3. France Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
11.4.4. France Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030
11.4.5. France Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
11.5. Spain
11.5.1. Spain Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030
11.5.2. Spain Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030
11.5.3. Spain Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
11.5.4. Spain Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030
11.5.5. Spain Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
11.6. Rest of Europe
11.6.1. Rest of Europe Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030
11.6.2. Rest of Europe Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030
11.6.3. Rest of Europe Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
11.6.4. Rest of Europe Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030
11.6.5. Rest of Europe Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
11.7. Europe PEST Analysis
CHAPTER 12. Asia Pacific Antibiotics Market By Country
12.1. Asia Pacific Antibiotics Market Overview
12.2. China
12.2.1. China Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030
12.2.2. China Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030
12.2.3. China Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
12.2.4. China Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030
12.2.5. China Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
12.3. Japan
12.3.1. Japan Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030
12.3.2. Japan Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030
12.3.3. Japan Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
12.3.4. Japan Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030
12.3.5. Japan Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
12.4. India
12.4.1. India Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030
12.4.2. India Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030
12.4.3. India Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
12.4.4. India Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030
12.4.5. India Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
12.5. Australia
12.5.1. Australia Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030
12.5.2. Australia Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030
12.5.3. Australia Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
12.5.4. Australia Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030
12.5.5. Australia Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
12.6. South Korea
12.6.1. South Korea Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030
12.6.2. South Korea Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030
12.6.3. South Korea Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
12.6.4. South Korea Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030
12.6.5. South Korea Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
12.7. Rest of Asia-Pacific
12.7.1. Rest of Asia-Pacific Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030
12.7.2. Rest of Asia-Pacific Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030
12.7.3. Rest of Asia-Pacific Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
12.7.4. Rest of Asia-Pacific Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030
12.7.5. Rest of Asia-Pacific Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
12.8. Asia Pacific PEST Analysis
CHAPTER 13. Latin America Antibiotics Market By Country
13.1. Latin America Antibiotics Market Overview
13.2. Brazil
13.2.1. Brazil Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030
13.2.2. Brazil Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030
13.2.3. Brazil Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
13.2.4. Brazil Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030
13.2.5. Brazil Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
13.3. Mexico
13.3.1. Mexico Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030
13.3.2. Mexico Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030
13.3.3. Mexico Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
13.3.4. Mexico Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030
13.3.5. Mexico Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
13.4. Rest of Latin America
13.4.1. Rest of Latin America Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030
13.4.2. Rest of Latin America Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030
13.4.3. Rest of Latin America Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
13.4.4. Rest of Latin America Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030
13.4.5. Rest of Latin America Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
13.5. Latin America PEST Analysis
CHAPTER 14. Middle East & Africa Antibiotics Market By Country
14.1. Middle East & Africa Antibiotics Market Overview
14.2. GCC
14.2.1. GCC Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030
14.2.2. GCC Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030
14.2.3. GCC Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
14.2.4. GCC Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030
14.2.5. GCC Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
14.3. South Africa
14.3.1. South Africa Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030
14.3.2. South Africa Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030
14.3.3. South Africa Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
14.3.4. South Africa Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030
14.3.5. South Africa Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
14.4. Rest of Middle East & Africa
14.4.1. Rest of Middle East & Africa Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030
14.4.2. Rest of Middle East & Africa Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030
14.4.3. Rest of Middle East & Africa Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
14.4.4. Rest of Middle East & Africa Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030
14.4.5. Rest of Middle East & Africa Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
14.5. Middle East & Africa PEST Analysis
CHAPTER 15. Player Analysis Of Antibiotics Market
15.1. Antibiotics Market Company Share Analysis
15.2. Competition Matrix
15.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
15.2.2. New Product Launches and Product Enhancements
15.2.3. Mergers And Acquisition In Global Antibiotics Market
15.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 16. Company Profile
16.1. Abbott Laboratories
16.1.1. Company Snapshot
16.1.2. Business Overview
16.1.3. Financial Overview
16.1.3.1. Revenue (USD Billion), 2021
16.1.3.2. Abbott Laboratories 2021 Antibiotics Business Regional Distribution
16.1.4. Product /Service and Specification
16.1.5. Recent Developments & Business Strategy
16.2. Allergan plc
16.3. Basilea Pharmaceutica Ltd.
16.4. Bayer Healthcare AG
16.5. F. Hoffmann-La Roche AG
16.6. GlaxoSmithKline PLC
16.7. Johnson & Johnson Inc.
16.8. Melinta Therapeutics
16.9. Merck & Co., Inc.
16.10. Novartis AG
16.11. Pfizer Inc.
16.12. Sanofi SA
16.13. Tetraphase Pharmaceuticals
To Get Premium Report Full Copy in Form of Single user or Multiple user@https://www.acumenresearchandconsulting.com/buy-now/0/2504
About Us:
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.